01970nas a2200397   4500000000100000008004100001260001300042653001500055653001000070653000900080653002200089653001000111653001600121653001100137653002800148653002500176653002000201653001500221653001100236653001000247653001200257653000900269653001600278653001900294653001500313653001500328653002200343100001300365700001300378700001400391245006900405300001000474490000700484520106700491022001401558       2003                            d  c2003 Feb10aAdolescent10aAdult10aAged10aAged, 80 and over10aChild10aChloroquine10aFemale10aGlaucoma, Angle-Closure10aGlaucoma, Open-Angle10aGlucocorticoids10aGonioscopy10aHumans10aIndia10aleprosy10aMale10aMiddle Aged10aOphthalmoscopy10aOptic Disk10aPrevalence10aTonometry, Ocular1 aThomas R1 aThomas S1 aMuliyil J00aPrevalence of glaucoma in treated multibacillary Hansen disease.  a16-220 v123 a<p><b>PURPOSE: </b>To determine the prevalence of glaucoma in a population of patients with multibacillary Hansen disease who had completed treatment.</p><p><b>PATIENTS AND METHODS: </b>The authors examined 386 of 446 patients with treated multibacillary Hansen disease residing in a geographically limited area. A complete ophthalmic examination including slit-lamp, applanation tonometry, gonioscopy, ophthalmoscopy, and stereobiomicroscopic examination of the optic disc was performed in all subjects. Glaucoma suspects were invited to the base hospital for further examination including automated perimetry.</p><p><b>RESULTS: </b>The overall prevalence of glaucoma was 3.6% (CI 1.9-5.3); 1.3% had primary open-angle glaucoma, 7% were primary angle-closure suspects (occludable angles), 1.8% had primary angle-closure glaucoma, and 0.5% had secondary glaucoma.</p><p><b>CONCLUSION: </b>The prevalence of primary glaucoma in patients with treated multibacillary Hansen disease was similar to that in the general population, and secondary glaucoma was rare.</p>  a1057-0829